Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Intensive glycaemic therapy for patients recently diagnosed with type 1 diabetes resulted in a decreased rate of long-term mortality compared with patients given conventional therapy, according to research published on 6 January 2014 in JAMA[1].
Researchers tracked the mortality and specific causes of death of 1,441 patients with type 1 diabetes mellitus for an average of 27 years until the end of 2012. The patients were originally recruited to the Diabetics Control and Complications Trial (DCCT), which took place between 1983 and 1993.
The DCCT divided patients into two groups – one received intensive therapy for an average of 6.5 years with the aim of achieving blood sugar control close to non-diabetic levels. The second group received conventional therapy aimed at avoiding hypoglycaemia.
http://www.pharmaceutical-journal.c...-diabetes-cuts-risk-of-death/20067516.article
Researchers tracked the mortality and specific causes of death of 1,441 patients with type 1 diabetes mellitus for an average of 27 years until the end of 2012. The patients were originally recruited to the Diabetics Control and Complications Trial (DCCT), which took place between 1983 and 1993.
The DCCT divided patients into two groups – one received intensive therapy for an average of 6.5 years with the aim of achieving blood sugar control close to non-diabetic levels. The second group received conventional therapy aimed at avoiding hypoglycaemia.
http://www.pharmaceutical-journal.c...-diabetes-cuts-risk-of-death/20067516.article
